| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 10/04/2001 | US20010026795 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system |
| 10/04/2001 | EP1138774A2 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatement |
| 10/04/2001 | EP1138773A2 Use of plasmids for the manufacture of a composition for vaccine treatment by human and animal |
| 10/04/2001 | EP1137792A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 10/04/2001 | EP1137779A2 Identification of senv genotypes |
| 10/04/2001 | EP1137764A1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase |
| 10/04/2001 | EP1137759A2 Live attenuated venezuelan equine encephalitis vaccine |
| 10/04/2001 | EP1137758A2 Method and composition for preserving viruses |
| 10/04/2001 | EP0835132B1 Recombinant temperature sensitive mutants of influenza virus |
| 10/04/2001 | EP0784693B1 Viral vectors for gene therapy |
| 10/04/2001 | DE10012861A1 Rekombinante HHV8-DNA Recombinant HHV8 DNA |
| 10/04/2001 | CA2404085A1 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising uroplakin-specific transcriptional regulatory sequences, and methods of use thereof |
| 10/02/2001 | US6297004 Retroviral particles that infect eukaryotic cells; for somatic gene therapy; for use as diagnostic tool in viral detection; viricides |
| 10/02/2001 | US6297003 Methods for the detection of a novel hepatitis C virus (HCV) terminal 3′ noncoding region |
| 10/02/2001 | US6296854 Live attenuated Venezuelan Equire encephalitis vaccine |
| 10/02/2001 | US6296845 Contacting under infective conditions, a recombinant replication deficient adenovirus lacking an expressed viral oncoprotein capable of binding functional p53 tumor suppressor gene product, with neoplastic cellsnon-neoplastic cells |
| 10/02/2001 | US6296807 Kits for the detection of human immunodeficiency virus type 2 (HIV-2) antigens |
| 09/27/2001 | WO2001071309A2 Methods and reagents for regulation of cellular responses in biological systems |
| 09/27/2001 | WO2001071017A2 Modified nodavirus rna for gene delivery |
| 09/27/2001 | WO2001070941A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 09/27/2001 | WO2001070932A2 Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife |
| 09/27/2001 | WO2001070175A2 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 09/27/2001 | WO2001070032A1 Recombinant parainfluenza virus expression systems and vaccines |
| 09/27/2001 | WO2001020013A3 Viral replicons and viruses dependent on inducing agents |
| 09/27/2001 | US20010025011 Environmental protection technique; bivalve-culture industries; host specific |
| 09/27/2001 | US20010024831 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 09/27/2001 | US20010024817 Viral nucleotide sequences |
| 09/27/2001 | US20010023664 Chicken anaemia viruses of low pathogenicity |
| 09/27/2001 | CA2403815A1 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 09/27/2001 | CA2403795A1 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 09/27/2001 | CA2403669A1 Methods and reagents for regulation of cellular responses in biological systems |
| 09/26/2001 | EP1136562A2 Feline leukemia virus vaccines |
| 09/26/2001 | EP1135513A1 Adenovirus-mediated gene therapy |
| 09/26/2001 | EP1135485A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/26/2001 | EP1135476A1 Biological compositions, components thereof and uses therefor |
| 09/26/2001 | EP1135469A1 An improved method for the production and purification of adenoviral vectors |
| 09/26/2001 | EP1135468A1 Virus vectors and methods of making and administering the same |
| 09/26/2001 | EP1135408A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| 09/26/2001 | EP1135162A2 Ordered molecular presentation of antigens, method of preparation and use |
| 09/26/2001 | CN1314948A Targeted adenovirus vectors for delivery of heterologous genes |
| 09/26/2001 | CN1314942A Newcastle disease virus infection clones, vaccine and diagnostic assays |
| 09/26/2001 | CN1314940A Temperature-sensitive and cold-adapted human parainfluenza virus type 2(HPIV-2) and vaccines based on such virus |
| 09/25/2001 | US6294377 Adenoviral vectors of canine origin |
| 09/25/2001 | US6294361 Processes for photoreactive inactivation of a virus in blood cell or coagulation factor containing compositions and use thereof for preparing compositions useful for transfusion |
| 09/25/2001 | US6294165 Vectors and their use in gene transfer. based on retroviruses, adapted so that they cannot package their own rna, and which can be used as infectious agents to transfer foreign genes, e.g. for somatic gene therapy. |
| 09/25/2001 | CA2110058C Hepatitis c virus (hcv) polypeptides |
| 09/20/2001 | WO2001068888A2 Production of chimeric capsid vectors |
| 09/20/2001 | WO2001068861A2 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IgE ANTIBODY AND USES THEREOF |
| 09/20/2001 | WO2001068833A2 Recombinant hhv8 dna |
| 09/20/2001 | WO2001068820A1 Altered strain of the modified vaccinia virus ankara (mva) |
| 09/20/2001 | WO2001068819A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine |
| 09/20/2001 | WO2001068708A2 Human and humanized fap-alpha-specific antibodies |
| 09/20/2001 | WO2001068695A2 Factor-h related protein 5 (fhr-5) and antibodies thereto |
| 09/20/2001 | WO2001067854A1 Chimeric animal model susceptible to human hepatitis c virus infection |
| 09/20/2001 | WO2000075335A3 Bacteriophage rm 378 of a thermophilic host organism |
| 09/20/2001 | WO2000046246A8 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
| 09/20/2001 | CA2402237A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine |
| 09/20/2001 | CA2401252A1 Human and humanized fap-alpha-specific antibodies |
| 09/20/2001 | CA2400825A1 Three-dimensional model of a fc region of an ige antibody and uses thereof |
| 09/20/2001 | CA2373414A1 A novel factor-h related protein 5 and antobodies thereto |
| 09/20/2001 | CA2373110A1 Production of chimeric capsid vectors |
| 09/19/2001 | EP1133520A2 Compositions and methods using lactadherin or variants thereof |
| 09/19/2001 | EP0612244B1 Endothelin receptor antagonists |
| 09/19/2001 | EP0593755B1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment |
| 09/19/2001 | CN1313864A Particles of HCV envelope proteins use of vaccination |
| 09/18/2001 | USRE37381 Attenuated cdna sequence; genetic engineering; mutants |
| 09/18/2001 | US6291236 Human cytomegalovirus DNA sequences |
| 09/18/2001 | US6291227 Nucleotide sequences coding viral polypeptides; for use in the development of vaccines which prevent retroviral infections |
| 09/18/2001 | US6291226 Adenovirus mutants with deleted protease gene |
| 09/18/2001 | US6291225 Microorganismal material for use in the treatment, diagnosis and prevention of microorganismal infection |
| 09/18/2001 | US6291157 Detecting retroviral antigens in samples by immunizing the host with an immunogenic non-infectious, non-replicating virus particles producing antibodies, mixing sample with retroviral antigen antibodies, detecting immune complexes |
| 09/18/2001 | US6290968 Genes are provided solely from the bovine rotavirus wc3 strain, or from both the human and bovine strains. |
| 09/18/2001 | US6290967 Stabilizers for lyophilized vaccines |
| 09/15/2001 | WO2001068859A2 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | CA2403370A1 Il-17 receptor like molecules and uses thereof |
| 09/13/2001 | WO2001066778A2 Production of foreign polypeptides in plants as viral coat protein fusions |
| 09/13/2001 | WO2001066715A2 Rapid generation of recombinant adenoviral vectors |
| 09/13/2001 | WO2001066566A2 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids |
| 09/13/2001 | WO2001066148A1 A method of sensitising endothelial cells to prodrugs |
| 09/13/2001 | WO2001009305A3 Purine metabolism genes in plants |
| 09/13/2001 | WO2001004282A3 Replication-competent anti-cancer vectors |
| 09/13/2001 | WO2001003744A3 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of the c, d or v genes |
| 09/13/2001 | WO1995021922A3 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
| 09/13/2001 | US20010021524 Viral-mediated gene transfer system |
| 09/13/2001 | US20010021517 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (MIF) gene selected from dirofilaria immitis MIF gene and Onchocerca volvulus MIF gene |
| 09/13/2001 | US20010021383 Antibodies for diagnosis, therapy |
| 09/13/2001 | CA2799545A1 Adenovirus formulations |
| 09/13/2001 | CA2403029A1 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids |
| 09/13/2001 | CA2402302A1 Production of foreign polypeptides in plants as viral coat protein fusions |
| 09/13/2001 | CA2402027A1 A method of sensitising endothelial cells to prodrugs |
| 09/12/2001 | EP1132478A2 Helper virus for the preparation of recombinant viral recombinants |
| 09/12/2001 | EP1132466A1 Chicken anaemia viruses of low pathogenicity |
| 09/12/2001 | EP1132398A2 DNA sequence encoding the specific and antigenic outer membrane protein of salmonella typhi |
| 09/12/2001 | EP1131458A1 Viral vectors with late transgene expression |
| 09/12/2001 | EP1131456A2 Vectors for gene mutagenesis and gene discovery by gene trapping |
| 09/12/2001 | EP1131414A1 Stable, attenuated rabies virus mutants and live vaccines thereof |
| 09/12/2001 | EP1131085A2 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 09/12/2001 | EP0666751B1 Mutants of hepatitis a virus strain hm-175 for use as hepatitis a vaccines |
| 09/12/2001 | CN1312725A Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 09/11/2001 | US6288218 Detecting gene expression in sample; incubate nucleotide sequences and primers, allow hybridization and detect hybridization products |